PSMC2 and osteosarcoma: PSMC2 was expressed highly in osteosarcoma patients; knockdown of PSMC2 reduced cell proliferation, migration, and increased apoptosis, which indicated that PSMC2 act as an oncogene for osteosarcoma [9].